United Guardian (UG) Capital Expenditures Growth (1y) (2011 - 2026)
Powered by 
Analysis
United Guardian (UG) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 26.65% |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 19.70% |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | 16.88% |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | 3.02% |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | -13.75% |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | -34.92% |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 73.63% |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 8.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.54% |
| Mar 31, 2026 | 174.00% |
| Dec 31, 2025 | -92.85% |
| Sep 30, 2025 | -50.21% |
| Jun 30, 2025 | -73.05% |
| Mar 31, 2025 | -83.57% |
| Dec 31, 2024 | 237.52% |
| Sep 30, 2024 | -55.28% |
| Jun 30, 2024 | 4,813.38% |
| Mar 31, 2024 | 750.35% |
| Dec 31, 2023 | 521.95% |
| Sep 30, 2023 | 42.93% |
| Jun 30, 2023 | -82.15% |
| Mar 31, 2023 | -46.65% |
| Dec 31, 2022 | -56.33% |
| Sep 30, 2022 | 10.71% |
| Jun 30, 2022 | -29.70% |
| Mar 31, 2022 | -82.81% |
| Dec 31, 2021 | 91.44% |
| Sep 30, 2021 | 92.68% |